Innovation is the mantra for the healthcare sector these days. From advanced biotech drugs to new A.I.-powered medical devices, the leaders in the sector are changing the face of medicine in a big way. And our latest Best Dividend Protection Stocks Model Portfolio pick is one such stock. Using its biotech muscle to power a decade’s worth of dividend growth. Investors can catch the opportunity before Wednesday, September 14, when the stock goes ex-dividend with a regular payout of $0.69/share. Interestingly, despite market volatility, our pick’s share price appreciated by 3.6% since being included in this portfolio on June 21, 2022.
Our pick was already one of the leading pharmaceutical stocks with a decade’s worth of strong innovation and blockbusters under its belt. However, in recent years, a focus on biotech has allowed it to create several major blockbuster drugs, especially for oncology related treatments. This has sent its cash flows into the stratosphere.
In addition to helping fund its dividend growth, it’s also allowed our pick to buy out smaller rivals and continue moving further into advanced drugs, creating a huge runway for dividend growth as well as future pipeline innovation.
In the end, our pick offers plenty of stable cash flows as well as potential- making ideal for conservative investors.
You can check out the Best Dividend Protection Stocks Model Portfolio to explore all the stocks.
